Global siRNA Drug Market Growth 2022-2028
The global research and development of siRNA drugs is still in the development stage of the industry. There are about 300 projects after the global laboratory stage, and the overall development trend is good. Its therapeutic areas are mainly concentrated in tumor, neurology and ophthalmology. Since siRNA has a larger molecular weight and stronger charge than ASO, it is more difficult for siRNA to enter cells by itself, so siRNA drugs have higher requirements for carriers, which is why siRNA drugs are approved later than ASO drugs big reason.
The global market for siRNA Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China siRNA Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key siRNA Drug players cover Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals and Arrowhead, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global siRNA Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global siRNA Drug market, with both quantitative and qualitative data, to help readers understand how the siRNA Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the siRNA Drug market and forecasts the market size by Type (Givlaari, Patisiran and Givosiran), by Application (Single Gene Rare Disease, Protein Deposition Disease, Chronic Liver Disease and Other), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Givlaari
Patisiran
Givosiran
Segmentation by application
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Genzyme
Alnylam
Dicerna
Quark Pharmaceuticals
Arrowhead
Exicure
Miragen Therapeutics
Silence
Sylentis
Avidity Biosciences
Dicerna
BioNTech
Moderna Therapeutics
The WhiteOak Group, Inc.
Chapter Introduction
Chapter 1: Scope of siRNA Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global siRNA Drug market size (sales and revenue) and CAGR, siRNA Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: siRNA Drug sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global siRNA Drug sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global siRNA Drug market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Genzyme, Alnylam, Dicerna, Quark Pharmaceuticals, Arrowhead, Exicure, Miragen Therapeutics, Silence and Sylentis, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global siRNA Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for siRNA Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for siRNA Drug by Country/Region, 2017, 2022 & 2028
2.2 siRNA Drug Segment by Type
2.2.1 Givlaari
2.2.2 Patisiran
2.2.3 Givosiran
2.3 siRNA Drug Sales by Type
2.3.1 Global siRNA Drug Sales Market Share by Type (2017-2022)
2.3.2 Global siRNA Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global siRNA Drug Sale Price by Type (2017-2022)
2.4 siRNA Drug Segment by Application
2.4.1 Single Gene Rare Disease
2.4.2 Protein Deposition Disease
2.4.3 Chronic Liver Disease
2.4.4 Other
2.5 siRNA Drug Sales by Application
2.5.1 Global siRNA Drug Sale Market Share by Application (2017-2022)
2.5.2 Global siRNA Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global siRNA Drug Sale Price by Application (2017-2022)
3 Global siRNA Drug by Company
3.1 Global siRNA Drug Breakdown Data by Company
3.1.1 Global siRNA Drug Annual Sales by Company (2020-2022)
3.1.2 Global siRNA Drug Sales Market Share by Company (2020-2022)
3.2 Global siRNA Drug Annual Revenue by Company (2020-2022)
3.2.1 Global siRNA Drug Revenue by Company (2020-2022)
3.2.2 Global siRNA Drug Revenue Market Share by Company (2020-2022)
3.3 Global siRNA Drug Sale Price by Company
3.4 Key Manufacturers siRNA Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers siRNA Drug Product Location Distribution
3.4.2 Players siRNA Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for siRNA Drug by Geographic Region
4.1 World Historic siRNA Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global siRNA Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global siRNA Drug Annual Revenue by Geographic Region
4.2 World Historic siRNA Drug Market Size by Country/Region (2017-2022)
4.2.1 Global siRNA Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global siRNA Drug Annual Revenue by Country/Region
4.3 Americas siRNA Drug Sales Growth
4.4 APAC siRNA Drug Sales Growth
4.5 Europe siRNA Drug Sales Growth
4.6 Middle East & Africa siRNA Drug Sales Growth
5 Americas
5.1 Americas siRNA Drug Sales by Country
5.1.1 Americas siRNA Drug Sales by Country (2017-2022)
5.1.2 Americas siRNA Drug Revenue by Country (2017-2022)
5.2 Americas siRNA Drug Sales by Type
5.3 Americas siRNA Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC siRNA Drug Sales by Region
6.1.1 APAC siRNA Drug Sales by Region (2017-2022)
6.1.2 APAC siRNA Drug Revenue by Region (2017-2022)
6.2 APAC siRNA Drug Sales by Type
6.3 APAC siRNA Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe siRNA Drug by Country
7.1.1 Europe siRNA Drug Sales by Country (2017-2022)
7.1.2 Europe siRNA Drug Revenue by Country (2017-2022)
7.2 Europe siRNA Drug Sales by Type
7.3 Europe siRNA Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa siRNA Drug by Country
8.1.1 Middle East & Africa siRNA Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa siRNA Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa siRNA Drug Sales by Type
8.3 Middle East & Africa siRNA Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of siRNA Drug
10.3 Manufacturing Process Analysis of siRNA Drug
10.4 Industry Chain Structure of siRNA Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 siRNA Drug Distributors
11.3 siRNA Drug Customer
12 World Forecast Review for siRNA Drug by Geographic Region
12.1 Global siRNA Drug Market Size Forecast by Region
12.1.1 Global siRNA Drug Forecast by Region (2023-2028)
12.1.2 Global siRNA Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global siRNA Drug Forecast by Type
12.7 Global siRNA Drug Forecast by Application
13 Key Players Analysis
13.1 Genzyme
13.1.1 Genzyme Company Information
13.1.2 Genzyme siRNA Drug Product Offered
13.1.3 Genzyme siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Genzyme Main Business Overview
13.1.5 Genzyme Latest Developments
13.2 Alnylam
13.2.1 Alnylam Company Information
13.2.2 Alnylam siRNA Drug Product Offered
13.2.3 Alnylam siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Alnylam Main Business Overview
13.2.5 Alnylam Latest Developments
13.3 Dicerna
13.3.1 Dicerna Company Information
13.3.2 Dicerna siRNA Drug Product Offered
13.3.3 Dicerna siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Dicerna Main Business Overview
13.3.5 Dicerna Latest Developments
13.4 Quark Pharmaceuticals
13.4.1 Quark Pharmaceuticals Company Information
13.4.2 Quark Pharmaceuticals siRNA Drug Product Offered
13.4.3 Quark Pharmaceuticals siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Quark Pharmaceuticals Main Business Overview
13.4.5 Quark Pharmaceuticals Latest Developments
13.5 Arrowhead
13.5.1 Arrowhead Company Information
13.5.2 Arrowhead siRNA Drug Product Offered
13.5.3 Arrowhead siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Arrowhead Main Business Overview
13.5.5 Arrowhead Latest Developments
13.6 Exicure
13.6.1 Exicure Company Information
13.6.2 Exicure siRNA Drug Product Offered
13.6.3 Exicure siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Exicure Main Business Overview
13.6.5 Exicure Latest Developments
13.7 Miragen Therapeutics
13.7.1 Miragen Therapeutics Company Information
13.7.2 Miragen Therapeutics siRNA Drug Product Offered
13.7.3 Miragen Therapeutics siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Miragen Therapeutics Main Business Overview
13.7.5 Miragen Therapeutics Latest Developments
13.8 Silence
13.8.1 Silence Company Information
13.8.2 Silence siRNA Drug Product Offered
13.8.3 Silence siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Silence Main Business Overview
13.8.5 Silence Latest Developments
13.9 Sylentis
13.9.1 Sylentis Company Information
13.9.2 Sylentis siRNA Drug Product Offered
13.9.3 Sylentis siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sylentis Main Business Overview
13.9.5 Sylentis Latest Developments
13.10 Avidity Biosciences
13.10.1 Avidity Biosciences Company Information
13.10.2 Avidity Biosciences siRNA Drug Product Offered
13.10.3 Avidity Biosciences siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Avidity Biosciences Main Business Overview
13.10.5 Avidity Biosciences Latest Developments
13.11 Dicerna
13.11.1 Dicerna Company Information
13.11.2 Dicerna siRNA Drug Product Offered
13.11.3 Dicerna siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Dicerna Main Business Overview
13.11.5 Dicerna Latest Developments
13.12 BioNTech
13.12.1 BioNTech Company Information
13.12.2 BioNTech siRNA Drug Product Offered
13.12.3 BioNTech siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 BioNTech Main Business Overview
13.12.5 BioNTech Latest Developments
13.13 Moderna Therapeutics
13.13.1 Moderna Therapeutics Company Information
13.13.2 Moderna Therapeutics siRNA Drug Product Offered
13.13.3 Moderna Therapeutics siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Moderna Therapeutics Main Business Overview
13.13.5 Moderna Therapeutics Latest Developments
13.14 The WhiteOak Group, Inc.
13.14.1 The WhiteOak Group, Inc. Company Information
13.14.2 The WhiteOak Group, Inc. siRNA Drug Product Offered
13.14.3 The WhiteOak Group, Inc. siRNA Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 The WhiteOak Group, Inc. Main Business Overview
13.14.5 The WhiteOak Group, Inc. Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. siRNA Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. siRNA Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Givlaari
Table 4. Major Players of Patisiran
Table 5. Major Players of Givosiran
Table 6. Global siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 7. Global siRNA Drug Sales Market Share by Type (2017-2022)
Table 8. Global siRNA Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global siRNA Drug Revenue Market Share by Type (2017-2022)
Table 10. Global siRNA Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 12. Global siRNA Drug Sales Market Share by Application (2017-2022)
Table 13. Global siRNA Drug Revenue by Application (2017-2022)
Table 14. Global siRNA Drug Revenue Market Share by Application (2017-2022)
Table 15. Global siRNA Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global siRNA Drug Sales by Company (2020-2022) & (K Units)
Table 17. Global siRNA Drug Sales Market Share by Company (2020-2022)
Table 18. Global siRNA Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global siRNA Drug Revenue Market Share by Company (2020-2022)
Table 20. Global siRNA Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers siRNA Drug Producing Area Distribution and Sales Area
Table 22. Players siRNA Drug Products Offered
Table 23. siRNA Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global siRNA Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global siRNA Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global siRNA Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global siRNA Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global siRNA Drug Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global siRNA Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global siRNA Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global siRNA Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 35. Americas siRNA Drug Sales Market Share by Country (2017-2022)
Table 36. Americas siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas siRNA Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 39. Americas siRNA Drug Sales Market Share by Type (2017-2022)
Table 40. Americas siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 41. Americas siRNA Drug Sales Market Share by Application (2017-2022)
Table 42. APAC siRNA Drug Sales by Region (2017-2022) & (K Units)
Table 43. APAC siRNA Drug Sales Market Share by Region (2017-2022)
Table 44. APAC siRNA Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC siRNA Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 47. APAC siRNA Drug Sales Market Share by Type (2017-2022)
Table 48. APAC siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 49. APAC siRNA Drug Sales Market Share by Application (2017-2022)
Table 50. Europe siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 51. Europe siRNA Drug Sales Market Share by Country (2017-2022)
Table 52. Europe siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe siRNA Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 55. Europe siRNA Drug Sales Market Share by Type (2017-2022)
Table 56. Europe siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 57. Europe siRNA Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa siRNA Drug Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa siRNA Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa siRNA Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa siRNA Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa siRNA Drug Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa siRNA Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa siRNA Drug Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa siRNA Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of siRNA Drug
Table 67. Key Market Challenges & Risks of siRNA Drug
Table 68. Key Industry Trends of siRNA Drug
Table 69. siRNA Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. siRNA Drug Distributors List
Table 72. siRNA Drug Customer List
Table 73. Global siRNA Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global siRNA Drug Sales Market Forecast by Region
Table 75. Global siRNA Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global siRNA Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC siRNA Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC siRNA Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa siRNA Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa siRNA Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global siRNA Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global siRNA Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global siRNA Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global siRNA Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global siRNA Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global siRNA Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global siRNA Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global siRNA Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. Genzyme Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Genzyme siRNA Drug Product Offered
Table 95. Genzyme siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Genzyme Main Business
Table 97. Genzyme Latest Developments
Table 98. Alnylam Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Alnylam siRNA Drug Product Offered
Table 100. Alnylam siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Alnylam Main Business
Table 102. Alnylam Latest Developments
Table 103. Dicerna Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Dicerna siRNA Drug Product Offered
Table 105. Dicerna siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Dicerna Main Business
Table 107. Dicerna Latest Developments
Table 108. Quark Pharmaceuticals Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Quark Pharmaceuticals siRNA Drug Product Offered
Table 110. Quark Pharmaceuticals siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Quark Pharmaceuticals Main Business
Table 112. Quark Pharmaceuticals Latest Developments
Table 113. Arrowhead Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Arrowhead siRNA Drug Product Offered
Table 115. Arrowhead siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Arrowhead Main Business
Table 117. Arrowhead Latest Developments
Table 118. Exicure Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Exicure siRNA Drug Product Offered
Table 120. Exicure siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Exicure Main Business
Table 122. Exicure Latest Developments
Table 123. Miragen Therapeutics Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Miragen Therapeutics siRNA Drug Product Offered
Table 125. Miragen Therapeutics siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Miragen Therapeutics Main Business
Table 127. Miragen Therapeutics Latest Developments
Table 128. Silence Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Silence siRNA Drug Product Offered
Table 130. Silence siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Silence Main Business
Table 132. Silence Latest Developments
Table 133. Sylentis Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Sylentis siRNA Drug Product Offered
Table 135. Sylentis siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Sylentis Main Business
Table 137. Sylentis Latest Developments
Table 138. Avidity Biosciences Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Avidity Biosciences siRNA Drug Product Offered
Table 140. Avidity Biosciences siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Avidity Biosciences Main Business
Table 142. Avidity Biosciences Latest Developments
Table 143. Dicerna Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Dicerna siRNA Drug Product Offered
Table 145. Dicerna siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Dicerna Main Business
Table 147. Dicerna Latest Developments
Table 148. BioNTech Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. BioNTech siRNA Drug Product Offered
Table 150. BioNTech siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. BioNTech Main Business
Table 152. BioNTech Latest Developments
Table 153. Moderna Therapeutics Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 154. Moderna Therapeutics siRNA Drug Product Offered
Table 155. Moderna Therapeutics siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Moderna Therapeutics Main Business
Table 157. Moderna Therapeutics Latest Developments
Table 158. The WhiteOak Group, Inc. Basic Information, siRNA Drug Manufacturing Base, Sales Area and Its Competitors
Table 159. The WhiteOak Group, Inc. siRNA Drug Product Offered
Table 160. The WhiteOak Group, Inc. siRNA Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. The WhiteOak Group, Inc. Main Business
Table 162. The WhiteOak Group, Inc. Latest Developments
List of Figures
Figure 1. Picture of siRNA Drug
Figure 2. siRNA Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global siRNA Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global siRNA Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. siRNA Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Givlaari
Figure 10. Product Picture of Patisiran
Figure 11. Product Picture of Givosiran
Figure 12. Global siRNA Drug Sales Market Share by Type in 2021
Figure 13. Global siRNA Drug Revenue Market Share by Type (2017-2022)
Figure 14. siRNA Drug Consumed in Single Gene Rare Disease
Figure 15. Global siRNA Drug Market: Single Gene Rare Disease (2017-2022) & (K Units)
Figure 16. siRNA Drug Consumed in Protein Deposition Disease
Figure 17. Global siRNA Drug Market: Protein Deposition Disease (2017-2022) & (K Units)
Figure 18. siRNA Drug Consumed in Chronic Liver Disease
Figure 19. Global siRNA Drug Market: Chronic Liver Disease (2017-2022) & (K Units)
Figure 20. siRNA Drug Consumed in Other
Figure 21. Global siRNA Drug Market: Other (2017-2022) & (K Units)
Figure 22. Global siRNA Drug Sales Market Share by Application (2017-2022)
Figure 23. Global siRNA Drug Revenue Market Share by Application in 2021
Figure 24. siRNA Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global siRNA Drug Revenue Market Share by Company in 2021
Figure 26. Global siRNA Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global siRNA Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global siRNA Drug Sales Market Share by Region (2017-2022)
Figure 29. Global siRNA Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas siRNA Drug Sales 2017-2022 (K Units)
Figure 31. Americas siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC siRNA Drug Sales 2017-2022 (K Units)
Figure 33. APAC siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe siRNA Drug Sales 2017-2022 (K Units)
Figure 35. Europe siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa siRNA Drug Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa siRNA Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas siRNA Drug Sales Market Share by Country in 2021
Figure 39. Americas siRNA Drug Revenue Market Share by Country in 2021
Figure 40. United States siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC siRNA Drug Sales Market Share by Region in 2021
Figure 45. APAC siRNA Drug Revenue Market Share by Regions in 2021
Figure 46. China siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe siRNA Drug Sales Market Share by Country in 2021
Figure 53. Europe siRNA Drug Revenue Market Share by Country in 2021
Figure 54. Germany siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa siRNA Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa siRNA Drug Revenue Market Share by Country in 2021
Figure 61. Egypt siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country siRNA Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of siRNA Drug in 2021
Figure 67. Manufacturing Process Analysis of siRNA Drug
Figure 68. Industry Chain Structure of siRNA Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets